VesugenAnti-AgingSafety Rating 6/10

Primary research areaCardiovascular health

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range10 mg SC daily for 10-day cycles, 1–2x/year. Often combined with other organ-specific bioregulators (Epithalon, Thymalin, Pinealon).
AdministrationVaries
Safety6/10 · Not FDA-approved
NCAA D1Not listed

Price Comparison

Compare vendors · per 20mg

7 vendors competing

VendorPrice$ / mgUpdated
SomaChemsBest $/mgCOA ✓ · 3P$51.99$64.99−20% · code PEPTIDEPRICES$2.60May 14, 2026Buy →
Behemoth LabzCOA ✓ · 3P$61.48$3.07May 14, 2026Buy →
PureRawzCOA ✓ · 3P$61.78$3.09May 14, 2026Buy →
Core PeptidesCOA ✓ · 3P$63.00$3.15Apr 16, 2026Buy →
Swiss ChemsCOA ✓ · 3P$63.00$3.15Apr 17, 2026Buy →
$25 off $100+·auto

Overview

About Vesugen

Mechanism of action

Tripeptide bioregulator targeting vascular tissue; modulates gene expression in endothelial and smooth muscle cells; promotes vascular wall repair and regeneration; reduces vascular aging and atherosclerotic changes.

Safety profile

Very well-tolerated. Minimal reported side effects. Decades of Russian research showing safety. Injection site reactions possible. · Russian bioregulator; short tripeptide; no adverse signals in available data; limited but clean

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Vesugen

Failed to fetch